Journal article

Safety and Efficacy Implications of Discontinuing Combination Ipilimumab and Nivolumab in Advanced Melanoma

MS Carlino, S Sandhu

Journal of Clinical Oncology | AMER SOC CLINICAL ONCOLOGY | Published : 2017

DOI: 10.1200/JCO.2017.75.2055

University of Melbourne Researchers

Citation metrics

10Scopus
10Web of Science
12Dimensions

Keywords

Science & Technology
3211 Oncology and Carcinogenesis
Life Sciences & Biomedicine
Pembrolizumab
3204 Immunology
Oncology
32 Biomedical and Clinical Sciences
Double-Blind
Cancer
Phase-3 Trial
Untreated Melanoma